| Virksomhedsstatus | | UNDER KONKURS. |
| Sidst opdateret den 24.08.2023 og
angivet som gældende fra 15.08.2023 (367
dage). |
| Historik | Start | Stop |
|---|
| UNDER KONKURS | 15.08.2023 | |
| UNDER REKONSTRUKTION | 31.07.2023 | 14.08.2023 |
| NORMAL | 12.10.2017 | 30.07.2023 |
| Branche | | Fremstilling af farmaceutiske præparater (212000). |
| Sidst opdateret den 17.10.2017 og
angivet som gældende fra 12.10.2017 (2500
dage). |
Ingen historik.
| Revisionfravalgt | | false. |
| Sidst opdateret den 17.10.2017 og
angivet som gældende fra 12.10.2017 (2500
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | Medican A/S. |
| Sidst opdateret den 08.02.2018 og
angivet som gældende fra 25.01.2018 (2395
dage). |
| Historik | Start | Stop |
|---|
| Medican A/S | 25.01.2018 | |
| Medican ApS | 12.10.2017 | 24.01.2018 |
| Binavne | | Medican Pharma A/S. |
| Sidst opdateret den 17.12.2020 og
angivet som gældende fra 17.12.2020 (1338
dage). |
| Historik | Start | Stop |
|---|
| Medican Pharma A/S | 17.12.2020 | |
| Remedium A/S | 17.12.2020 | |
| Danish Cannabis Production A/S | 07.02.2018 | 16.12.2020 |
| Dansk Cannabis Produktion A/S | 07.02.2018 | 16.12.2020 |
| Medcan A/S | 07.02.2018 | 16.12.2020 |
| Medicinsk Cannabis A/S | 07.02.2018 | 16.12.2020 |
| Danish Cannabis Production ApS | 12.10.2017 | 06.02.2018 |
| Dansk Cannabis Produktion ApS | 12.10.2017 | 06.02.2018 |
| Medcan ApS | 12.10.2017 | 06.02.2018 |
| Medicinsk Cannabis ApS | 12.10.2017 | 06.02.2018 |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening, af bestyrelsesformanden i forening med to bestyrelsesmedlemmer eller af den samlede bestyrelse | 16.07.2019 | 15.08.2023 |
| Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening eller af den samlede bestyrelse | 07.02.2018 | 15.07.2019 |
| Selskabet tegnes af en direktør og et bestyrelsesmedlem i forening | 18.10.2017 | 06.02.2018 |
| Selskabet tegnes af direktionen i forening | 12.10.2017 | 17.10.2017 |
Ingen nuværende registrering.
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:Baker Tilly Denmark
Revisionsvirksomhedens CVR-nr.:35257691
Beskrivelse af revisor:statsautoriseret revisor
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):We have not been able to obtain sufficient and suitable audit evidence for the valuation of the deferred tax asset as of 30 June 2022. We have thus not received sufficient documentation that the tax losses can be utilized in the form of operating profits within a short number of years. According to our assessment, the tax asset of DKK 15,636k should be recognized at DKK 0.
We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the “Auditor's responsibilities for the audit of the financial statements” section of our report. We are independent of the company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion.
Konklusion (revision):We have audited the financial statements of Medican A/S for the financial year 1 July 2021 - 30 June 2022, which comprise a summary of significant accounting policies, income statement, balance sheet, statement of changes in equity and notes. The financial statements are prepared under the Danish Financial Statements Act.
In our opinion, except for the potential effects of the matter(s) described in the “Basis for Qualified Opinion” paragraph, the financial statements give a true and fair view of the company's financial position at 30 June 2022 and of the results of the company's operations for the financial year 1 July 2021 - 30 June 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on management's review
Management is responsible for management's review.
Our opinion on the financial statements døs not cover management's review, and we do not express any form of assurance conclusion thereon.
In connection with our audit of the financial statements, our responsibility is to read management's review and, in doing so, consider whether management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether management's review provides the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration